Metraipolis › archive › dc_732111b244ba

Nanomedicine against oxaliplatin-induced peripheral neuropathy: hypotheses and research perspectives on ion channels and immune microenvironment — Europe PMC PMID:42108321

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42108321
DOI
10.1186/s43046-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-02T12:18:26.916Z
SHA-256 of the archived text
af2c8f4a9e3f117b57d1a2b5d284e728ab5a2549f68130adf92f03e09d8549e6
Stable URL of this page
https://metraipolis.com/documento/dc_732111b244ba

How to cite

Nanomedicine against oxaliplatin-induced peripheral neuropathy: hypotheses and research perspectives on ion channels and immune microenvironment — Europe PMC PMID:42108321 — Europe PMC (en), https://europepmc.org/article/MED/42108321 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_732111b244ba (Metraipolis archive dc_732111b244ba, sha256 af2c8f4a9e3f117b57d1a2b5d284e728ab5a2549f68130adf92f03e09d8549e6)
BibTeX
@misc{dc732111b244ba,
  title = {Nanomedicine against oxaliplatin-induced peripheral neuropathy: hypotheses and research perspectives on ion channels and immune microenvironment — Europe PMC PMID:42108321},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42108321},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_732111b244ba; sha256 af2c8f4a9e3f117b57d1a2b5d284e728ab5a2549f68130adf92f03e09d8549e6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42108321. Agents can read the archived copy with the MCP tool read_document.